VerbatimParliament, as it happens

Drugs: Safety

Asked by James McMurdockIndependentDepartment of Health and Social CareTabled Answered 27 January 2026UIN 102543

The question

To ask the Secretary of State for Health and Social Care, whether additional resources have been provided to the Medicines and Healthcare products Regulatory Agency to support winter‑related medicine safety surveillance.

Answered by Dr Zubir Ahmed

The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicines for human use, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet appropriate standards of safety, quality, and efficacy.

Safety surveillance activity at the MHRA is funded through the annual service fee. Recent and sufficient fee increases mean that this funding now covers all required surveillance activity, with separate Living with COVID funding helping to support periods of peak demand.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim